faq

FAQs

What is Adhera Therapeutics?

Adhera Therapeutics’ focus is to treat the intersection of arthritis, pain, hypertension, and oncology diseases using combination therapies of already approved drugs. The company is developing and commercializing late stage, non-addictive pain therapeutics. The company’s ‘next-generation of celecoxib,’ including IT-102 and IT-103, are designed to control the dangerous side-effect of edema that prohibits the drug from being prescribed at higher doses. These have the potential of replacing opioids and combatting the opioid epidemic.


What year was Adhera Therapeutics founded?

Adhera Therapeutics was originally founded as Nastech Pharmaceutical Company on September 23, 1983; the company changed its name to Marina Biotech on July 21, 2010.


Where is Adhera Therapeutics headquartered?

17870 Castleton Street, Suite 250
City of Industry, CA 91748


Who are Adhera Therapeutics’ top executives?

Meet our management team.


Where is Adhera Therapeutics incorporated?

Adhera Therapeutics is incorporated in the State of Delaware.


When did Adhera Therapeutics go public?

Adhera Therapeutics went public in 1984 under the name “Nastech Pharmaceutical Company” and changed its name to “Marina Biotech” on July 21, 2010.


Where does Adhera Therapeutics trade and what is the ticker symbol?

Adhera Therapeutics’ common stock is traded on the OTCQB under the symbol “MRNA


When are quarterly financial results announced and how can I stay informed?

All events will be reported on this site within the timeframe allotted by the SEC (45 days from the end of the quarter; 90 days from the end of the fiscal year December 31st), unless announced otherwise. Please see the event page for more information.


How do I invest in Adhera Therapeutics?

If you would like to purchase shares in Adhera Therapeutics, please contact your broker.


What is Adhera Therapeutics’ fiscal year?

Adhera Therapeutics’ fiscal year ends on December 31.


Who is Adhera Therapeutics’ transfer agent?

The transfer agent and registrar for the company’s common stock is:

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 718-921-8360
Fax: 718-765-8719


Does Adhera Therapeutics pay a dividend?

No, Adhera Therapeutics does not pay a dividend.


Does Adhera Therapeuticsh offer a Direct Stock Purchase Plan?

No, Adhera Therapeutics does not offer a Direct Stock Purchase Plan.


Where do I find SEC filings?

You can go to the official SEC site or you can follow this link to our page.


Who are Adhera Therapeutics’ independent auditors?

Squar Milner LLP.


Do you have another question that hasn’t been answered?

Investor inquiries should be directed to:

Garth Russell / Allison Soss
KCSA Strategic Communications
Phone: 212.896.1250 / 212.896.1267
Email: grussell@kcsa.com / asoss@kcsa.com

Scroll Up